MedTrace Logo

Results Of Patient Rated Asthma Control Test In Comparison To Diary Card Data

NCT00363480 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 221

Last updated 2018-03-09

Study results available
· View outcomes & findings →

Summary

The majority of asthma patients are not well controlled, despite the availability of asthma medication that could effectively treat the disease. In this study uncontrolled patients who are steroid-naive or on low dose inhaled corticosteroids will be treated with Seretide (salmeterol/fluticasone combination, SFC) 50/250 µg twice daily. The asthma control test (ACT) will be used to detect differences in the level of asthma control during treatment. The study aims to show a correlation between improvements of ACT und the level of asthma control which will be reached by the patients.

The aim of the study is to show that most of symptomatic asthma patients can reach 'well controlled asthma' with SFC. We get information about ACT in daily practice and physicians are trained to use the asthma control test as a screening tool and for follow up of asthma management. Correlations are expected between the improvements in ACT, Quality of Life and asthma control according to the Gaining Optimal Asthma controL (GOAL) criteria.

Conditions

Interventions

DRUG

Salmeterol/Fluticasone 50/250 mcg

Participant received salmeterol/fluticasone combination 50/250 mcg using DISKUS™ powder inhalers.

DRUG

Salbutamol 100 mcg

This medication was provided in metered dose inhalers containing at least 200 puffs of 100 mcg salbutamol.

DEVICE

DISKUS™ powder inhalers

Participant received salmeterol and fluticasone using DISKUS™ powder inhalers.

Sponsors & Collaborators

Principal Investigators

  • GSK Clinical Trials · GlaxoSmithKline

Study Design

Allocation
NON_RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2006-05-17
Primary Completion
2007-09-01
Completion
2007-09-14

Countries

  • Germany

Study Locations

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00363480 on ClinicalTrials.gov